SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review

The prevalence of diabetes and its associated complications is increasing throughout the decades. Promising diabetes medications were introduced to the market including GLP-1 agonists, DPP-4 inhibitors, and SGLT2 inhibitors aiming to target these complications. The literature lacks sufficient data r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Endocrinol
Main Authors: El Mouhayyar, Christopher, Riachy, Ruba, Khalil, Abir Bou, Eid, Asaad, Azar, Sami
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2020
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066394/
https://ncbi.nlm.nih.gov/pubmed/32190049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/1762164
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares